Astrazeneca Recieves Appraisal Opinion From Shenzhen City Customs Office Regarding Suspected Unpaid Importation Taxes Amounting To $1.6 Mln

April 29 (Reuters) - AstraZeneca PLC AZN.L:

• ASTRAZENECA Q1 CORE EPS $2.49

• ASTRAZENECA - Q1 TOTAL REVENUE $13,588 MILLION

• ASTRAZENECA: GOT APPRAISAL OPINION FROM SHENZHEN CITY CUSTOMS OFFICE REGARDING SUSPECTED UNPAID IMPORTATION TAXES AMOUNTING TO $1.6 MILLION

• Q1 EARNINGS PER SHARE VIEW $2.21, REVENUE VIEW $13.74 BILLION -- LSEG IBES DATA

• FY2025 EARNINGS PER SHARE VIEW $8.96, REVENUE VIEW $57.54 BILLION -- LSEG IBES DATA

• ASTRAZENECA: "MAKING EXCELLENT PROGRESS TOWARD OUR AMBITION OF EIGHTY BILLION DOLLARS IN TOTAL REVENUE BY 2030"

• ASTRAZENECA - REITERATES ITS TOTAL REVENUE AND CORE EPS GUIDANCE FOR FY 2025 AT CER

• ASTRAZENECA - TRANSFER TO PROSECUTOR NOTICE FROM SHENZHEN BAO’AN DISTRICT PUBLIC SECURITY BUREAU FOR SUSPECTED UNLAWFUL COLLECTION OF PERSONAL INFO

• ASTRAZENECA - CORE TAX RATE IS EXPECTED TO BE BETWEEN 18-22% FOR FY25

• ASTRAZENECA - IN FY 2025, INTENDS TO INCREASE ANNUAL DIVIDEND PER SHARE DECLARED TO $3.20 PER SHARE

• ASTRAZENECA - IN FY 2025, EXPECTS TO INCREASE EXPENDITURE ON TANGIBLE ASSETS AND SOFTWARE-RELATED INTANGIBLE ASSETS BY 50%

Source text: [ID:]

Further company coverage: AZN.L